Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

The Multiple Health Benefits Of Dairy Foods Examined By New Science Review
WHAT: Food prices rose by 5.5 percent in the past year and are expected to increase up to an additional 4 percent in 2009. Americans are seeking to get the most out of their dollar, and since together, dairy foods provide a unique package of nine essential nutrients, they are a nutritional bang for the buck.
generic viagra online
MAP Pharmaceuticals Phase 3 Trial Of Levadex™ Migraine Product Candidate Meets All Four Primary Endpoints
MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) announced that the efficacy portion of its first Phase 3 clinical trial evaluating its novel LEVADEX™ orally inhaled migraine therapy met all four primary endpoints. Additional endpoints showed that LEVADEX provided rapid and sustained pain relief for up to 48 hours after dosing.
News of the day
Management Insights Study Warns That State Privacy Rules Reduce Electronic Medical Sharing
States that have passed privacy laws restricting the ability of hospitals to disclose patient information have seen the sharing of electronic medical records suffer by more than 24%, according to the Management Insights feature in the current issue of Management Science, the flagship journal of the Institute for Operations Research and the Management Sciences (INFORMS®).
Health Insurance

Multidisciplinary Cancer Congress

ECCO 15 - ESMO 34 will take place at the ICC Berlin - Internationales Congress Centrum, Messedamm 22, D-14055 Berlin, Germany (http://www.icc-berlin.de) from Sunday 20 September to Thursday 24 September 2009. ECCO 15 - ESMO 34 will build on the success of the previous ECCO (European Cancer Conference) and ESMO (European Society for Medical Oncology) conferences. It provides a unique European forum for presentations of cutting-edge research from experimental and clinical oncologists, epidemiologists and cancer nurses. Over 15,000 scientists, doctors, nurses, patients, carers and industry representatives are expected to attend. More than 100 experts in different cancer fields have developed a wide-ranging and exciting congress programme, with large numbers of reports of translational research and first reports from high quality phase III clinical trials. In addition, for the first time there will be an "oncopolicy" track; this has been introduced to help inform European policy on cancer and to ensure its place at the top of the EU health and research policy agenda. Mary Rice ECCO-the European CanCer Organisation


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009